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A changing paradigm for health research 
 Research often fails to inform the choices faced by clinicians, 
patients, payors, policy-makers  
 Need head-to-head comparisons of all relevant choice options and 
combinations 
 Need evidence on effectiveness in real-world clinical & community 
settings 
 Need to know whether/why interventions work for some and not for 
others (treatment heterogeneity) 
 Need to determine value from the consumer’s perspective  
(patient-centered outcomes and costs) 
 
 
 
CER Defined 
 “Comparative effectiveness research is the generation and synthesis 
of evidence that compares the benefits and harms of alternative 
methods to prevent, diagnose, treat, and monitor disease and 
improve the delivery of care.  
 The purpose of CER is to assist consumers, clinicians, purchasers, and 
policy makers to make informed decisions that will improve health 
care at both the individual and population levels.” 
 
-National Academy of Sciences  
Institute of Medicine, 2009 
 
 
PCOR Defined 
Patient-Centered Outcomes Research (PCOR) helps people and their caregivers 
communicate and make informed health care decisions, allowing their voices to 
be heard in assessing the value of health care options. This research answers 
patient-centered questions such as: 
• “Given my personal characteristics, conditions and preferences, what should 
I expect will happen to me?” 
• “What are my options and what are the potential benefits and harms of 
those options?” 
• “What can I do to improve the outcomes that are most important to me?” 
• “How can clinicians and the care delivery systems they work in help me 
make the best decisions about my health and healthcare?” 
 
 
PCOR Defined 
To answer these questions, PCOR: 
• Assesses the benefits and harms of preventive, diagnostic, therapeutic, 
palliative, or health delivery system interventions to inform decision making, 
highlighting comparisons and outcomes that matter to people; 
• Is inclusive of an individual’s preferences, autonomy and needs, focusing on 
outcomes that people notice and care about such as survival, function, 
symptoms, and health related quality of life; 
• Incorporates a wide variety of settings and diversity of participants to address 
individual differences and barriers to implementation and dissemination; and 
• Investigates optimizing outcomes while addressing burden to individuals, 
availability of services, technology, and personnel, and other stakeholder 
perspectives 
 
 
Recent developmental history 
 2003 Medicare Modernization Act: $30M annually for research to improve 
quality, effectiveness, efficiency  
 2007 federal legislation to expand CER passed House  
but failed Senate 
 2009 ARRA:  $1.1B to NIH and AHRQ for CER 
             Federal Coordinating Council for CER established 
             IOM Top 100 Priority Topics for CER identified 
 50% involve health care delivery system 
 33% address health care disparities 
 20% address patient functional limitations or disabilities 
 2010 ACA: scale up to ≈$500M annually through Patient Centered Outcomes 
Research Institute 
 2011 ACA: $10M for Public Health CER at CDC 
 
 
 
PCOR Research Priorities 
 Assessment of prevention, diagnosis, and treatment options 
 Improving healthcare systems 
 Communication and dissemination research 
 Addressing health disparities 
 Accelerating Patient-Centered Outcomes Research and 
Methodological Research  
 
• Compare the effectiveness of two or more strategies for prevention, treatment, 
screening, diagnosis, or management that have not been adequately studied against 
alternative options. Topics are not limited to medical or surgical therapy and may include 
a range of strategies including self-care. 
• Special emphasis is placed on studies conducted in typical clinical populations 
considering the full range of relevant patient-centered outcomes and possibilities that 
results may differ among patient groups based on patient characteristics (understood 
broadly as possibly including clinical, psychosocial, demographic, and other domains) or 
preferences. 
•  Compare the use of prognostication/risk-stratification tools with usual clinical 
approaches to treatment selection or administration. 
•  Compare the key determinants of the outcomes patients experience following treatment 
decisions, with attention to various patient factors, including demographic, biological, 
clinical, social, economic, and geographic factors that may influence the outcomes that 
follow a specific treatment. 
Prevention & Treatment Options Research 
• Research that compares alternative system-level approaches to supporting and 
improving patient access to care; receipt of appropriate evidence-based care; the 
quality, timeliness, and safety of the patient care experience; decision-making based 
on patients’ personal values; and self-care.  
• Research that compares alternative approaches to models of care delivery or 
coordination of care across healthcare services or settings, including care for patients 
with complex, chronic, and/or multiple conditions, are of interest. The emphasis is on 
comparing approaches for their effect on patients and, when relevant, their caregivers, 
in ways that they experience and think are important. 
• Research that compares alternative system-level approaches that aim to improve the 
efficiency of health care delivery to patient populations. These may include efforts to 
reduce the use of ineffective or wasteful care, to reduce redundant and duplicative 
care, to shorten waiting times, or enhance the timeliness and quality of 
communications during referrals and transitions in care. 
Delivery Systems Research 
• Compare alternative communication, dissemination, health literacy and/or 
implementation strategies that aim to improve patients’ health outcomes, by increasing 
patient, caregiver, and/or provider awareness of health care options in clinical or 
community-based settings. 
• Compare the effectiveness of alternative approaches across a range of patient centered 
outcomes to increase or encourage effective patient, caregiver, or clinician 
participation in care decisions and in shared decision making. 
• Compare alternative methods and tools to elicit and include patient desired outcomes 
in the health care decision making process. 
• Compare alternative approaches, including use of public health strategies or social 
media, for providing new information to patients, caregivers, or clinicians, with 
attention to differences in effectiveness in different populations. 
• Compare innovative approaches in the use of existing electronic clinical data and other 
electronic modalities from the healthcare system or from a network of systems to 
enhance clinical decision making by patients and providers. 
Communication & Dissemination Research 
• Compare interventions to reduce or eliminate disparities in patient-centered 
outcomes, including health, health care, and patient-reported outcomes. For 
example, by accounting for possible differences at the patient, provider, or systems 
level, determine what interventions can be most effective for eliminating disparities 
in outcomes. 
• Compare promising practices that address contextual factors such as socioeconomic, 
demographic, or community factors and their impact on patient-centered health 
outcomes. 
• Compare benefits and risks of treatment, diagnostic, prevention, or service options 
across different patient populations, with attention to eliminating disparities. 
• Research that compares strategies to overcome patient, provider, or systems level 
barriers (e.g. language, culture, transportation, homelessness, unemployment, lack 
of family/caregiver support) that may adversely affect patients and are relevant to 
their choices for preventive, diagnostic, and treatment strategies—as well as patient-
centered outcomes. 
• Compare and identifies best practices within various patient populations for 
information sharing about treatment outcomes and research. 
Disparities Research 
• Identify optimal methods for engaging patients in the research process, and methods 
for evaluating the impact on research outcomes of patient engagement in the research 
process.  
• Identify methods for conduct of systematic reviews of patient-centered comparative 
effectiveness research topics. 
• Test methods for including patients and stakeholders in generating, selecting, and 
prioritizing topics for research, 
• Test methods for including patients and stakeholders in the peer-review process. 
• Improve the validity and/or efficiency of analytic methods for comparative 
effectiveness research (e.g., approaches for strengthening causal inference in 
observational and randomized studies; approaches to identifying and confirming 
heterogeneity in treatment effects). 
• Determine the validity and efficiency of data sources commonly used in PCOR. 
• Develop new patient-reported outcomes measures. 
• Evaluate and compare strategies for training researchers, patients, and other 
stakeholders in PCOR methods. 
Methods Research 
Where Does Public Health Fit in CER/PCOR? 
 Public health roles in community engagement, priority setting, 
preference assessment 
 Public health roles in prevention delivery 
 Use of public health strategies to improve health care systems 
 Public health system roles in communication and 
dissemination  
 Public health system roles in health information exchange, 
quality measurement, and reporting 
 Public health system roles in disparities reduction 
Valuing Prevention & Public Health  
Institute of Medicine.  An Integrated Framework for Assessing the 
Value of Community-Based Prevention.  Washington, DC; 2012.   
Methods in CER and PCOR 
PCORI Draft Methodology Report 
 Stakeholder engagement and patient centeredness 
 Prioritizing research topics 
 Choosing a study design 
 Designing, conducting, and reporting results 
 
Methods in CER and PCOR 
 Prospective, pragmatic trials and “large simple trials” 
 Advanced analytic methods used to strengthen internal validity and limit bias 
due to selection, confounding in observational studies 
 Propensity score and instrumental variables models 
 Explicit testing for treatment heterogeneity 
 Latent variable models for multiple interventions, 
multiple outcomes 
 Non-inferiority analyses 
 Development and integration of large clinical and  
administrative data sources and registries  
 Use of Bayesian models for synthesizing  data from  
multiple studies, e.g. indirect treatment comparisons 
 
Expanding Role of Pragmatic Trials 
http://www.cabinetoffice.gov.uk/resource-library/test-learn-adapt-developing-
public-policy-randomised-controlled-trials 
Estimating Treatment Heterogeneity 
Programs/Policies/Interventions may affect some people 
differently than others   
Interventions may be moderated by community contextual 
factors, socioeconomic conditions, cultural and linguistic 
characteristics, individual health status and comorbidities 
If you know and measure all relevant modifiers, traditional 
statistical methods can be used 
Often, important modifiers may be unknown, others imperfectly 
measured 
Instrumental-variables methods provide the most viable 
solution for estimating “person-centered” effects 
Estimating Treatment Heterogeneity 
Basu et al. Estimating person-centered treatment effects using instrumental variables.  
J Health Econ 2012.   
Methods in CER and PCOR 
PCORI Draft Methodology Report 
 Stakeholder engagement and patient centeredness 
 Prioritizing research topics 
 Choosing a study design 
 Designing, conducting, and reporting results 
 
Example: Pragmatic Trials in PBRNs 
Improving Cultural Competency of Public Health Workers 
Question of interest: Can a health professions cultural 
competency training program be adapted to improve skills 
among local public health workers?  
Practice settings: 56 local agencies 
Factors examined:  
– Knowledge and skills related to  
CLAS standards 
– RE-AIM measures of success 
Study design: random-assignment delayed intervention trial 
Example: Estimating Treatment Heterogeneity  
in PBRNs 
Effects of Medicaid Maternity Case Management Payment 
Model Change in North Carolina 
Policy change may affect some populations differently  
from others 
Women served by LHDs vs. other community providers 
Women in communities with more vs.  
less abundant community resources 
Women with comorbid conditions and 
higher-risk pregnancies 
Use Bayesian CER methods, propensity score 
estimation, instrumental-variables estimation for person-
centered treatment (PET) effects 
 
Example: Comparative efficiency of a 
delivery system innovation 
Arkansas Community Connector Program uses public 
health-trained community health workers to identify and 
link elderly and disabled populations to community-
based services and supports to avoid/delay need for 
institutional care 
Compare the CCP program to “usual practice” on 
Medicaid expenditures for elderly and disabled 
recipients eligible for long-term care services 
Determine whether the CCP program is cost-neutral to 
Medicaid after accounting for both Medicaid 
expenditures and program operating costs 
Felix HC, Mays GP, Stewart MK, Cottoms N, Olson M. Medicaid savings resulted when 
community health workers linked those with needs to home and community care. 
Health Affairs. 2011;30(7):1366-1374. 
Methods: Comparison Group 
CCP participants 
Comparison Group: statistically 
matched on age, gender, race, eligibility 
category, enrollment duration, waiver 
enrollment, comorbidities, prior-year 
spending 
Results of propensity score matching 
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Distribution of Propensity Score 
CCP Participants Comparison Group 
Approximate a “statistically equivalent” control group that 
would be generated by random assignment. Each subject has 
an equivalent probability of being a CCP participant.  
Estimates of Program Impact 
Regression-Adjusted Spending Estimates 
CER/PCOR Funding Opportunities 
 PCORI: third round deadlines in Spring 2013 
 AHRQ: next round of awards scheduled for Spring 2013 
 RWJF PHSSR awards program (current deadline Dec 18) 
 RWJF PBRN Program (forthcoming funding 2013) 
 Special RWJF/CTSA solicitation this winter 
 NIH Common Fund: health economics program 
 CMS Innovation Fund projects 
 CDC Community Transformation Grant projects 
 
The Robert Wood Johnson Foundation’s 
Public Health PBRN Program 
First cohort (December 2008 start-up)
Second cohort (January 2010 start-up)
Affiliate/Emerging PBRNs
National 
Coordinating 
Center
Concluding Questions 
 How can we help the public health community become aware 
of opportunities in PCOR and CER? 
 How can we help the public health community position to be 
successful with PCOR and CER funding? 
 Meaningful stakeholder engagement 
 Rigorous research design and methods 
 Preliminary data 
 Multi-network studies, large simple trials 
 Collaborations with primary care PBRNs, CTSAs, etc 
 How can we facilitate the productive dissemination and use of 
PCOR and CER evidence via the public health system? 
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